Glen Eagle Advisors, LLC Cybin Inc. Call Options Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYBN
# of Institutions
63Shares Held
266MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT58.1MShares$663 Million0.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA44MShares$502 Million0.18% of portfolio
-
Logos Global Management LP San Francisco, CA40MShares$456 Million1.01% of portfolio
-
Avidity Partners Management LP Dallas, TX34.9MShares$398 Million0.46% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L325.6MShares$292 Million1.01% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $1.89B
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...